A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment

---

Karatayli E., Karayalcin S., Karaaslan H., KAYHAN H., Turkyilmaz A. R., Sahin F., ...More

ANTIVIRAL THERAPY, vol.12, no.5, pp.761-768, 2007 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 12 Issue: 5
• Publication Date: 2007
• Journal Name: ANTIVIRAL THERAPY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.761-768
• Gazi University Affiliated: No

Abstract

Aims: This study was conducted to clarify the resistance profile of a novel mutation pattern emerging during lamivudine (3TC) therapy and showing cross-resistance to adefovir dipivoxil (ADV) in a patient with chronic hepatitis B.